Search

Your search keyword '"Sager, Philip T."' showing total 45 results

Search Constraints

Start Over You searched for: Author "Sager, Philip T." Remove constraint Author: "Sager, Philip T." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
45 results on '"Sager, Philip T."'

Search Results

1. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial

5. First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301)

8. Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium

9. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial

10. Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm

12. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2

13. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2

19. Abstract 11430: Etripamil Nasal Spray Reduces Heart Rate in Patients with Paroxysmal Supraventricular Tachycardia Prior to Conversion to Sinus Rhythm

21. Assessment of Multi‐Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study

25. The FDA Workshop on Improving Cardiotoxicity Assessment with Human-Relevant Platforms

28. Assessment of Multi‐Ion Channel Block in a Phase I Randomized Study Design: Results of the Ci PA Phase I ECG Biomarker Validation Study

29. Cardiovascular Safety During and After Use of Phentermine and Topiramate

31. Is there a role for pharmacokinetic/pharmacodynamic-guided dosing for novel oral anticoagulants?

35. Tissue and Animal Models of Sudden Cardiac Death

36. The Potential Role of the J‐Tpeak Interval in Proarrhythmic Cardiac Safety: Current State of the Science From the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium.

37. The Cardiac Safety Research Consortium enters its second decade: An invitation to participate

41. Drug‐induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and Pharmacy.

42. Cardiovascular Safety During and After Use of Phentermine and Topiramate.

45. Effects of the Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist Dulaglutide on Ambulatory Blood Pressure and Heart Rate in Patients With Type 2 Diabetes Mellitus

Catalog

Books, media, physical & digital resources